Brenda Herschbach Jarrell > Choate, Hall & Stewart > Boston, United States > Lawyer Profile
Choate, Hall & Stewart Offices
TWO INTERNATIONAL PLACE
BOSTON, MA 02110
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Brenda Herschbach Jarrell
Position
Dr. Brenda Herschbach Jarrell, chair of Choate’s Life Sciences Group, is described by clients as an IP lawyer with keen business savvy. Her extensive technical credentials make her well-versed in a wide variety of technologies in the biotech, pharmaceutical, and specialty chemical industries. She represents companies and institutions at all stages of the life sciences business lifecycle, as well as those who invest in them, guiding IP protection and competitive positioning strategies, negotiating strategic transactions, and providing creative solutions to IP and technology-related challenges. Throughout her career, Brenda has advised multiple clients from Series A through their eventual IPOs.
As one of the foremost respected IP strategists in the country, Brenda is routinely awarded the recognition of “Attorney of the Year” by several respected rankings providers across a variety of categories.
Some of her clients include Adimab, Aleta Biotherapeutics, Angion Biomedica Corp., Apellis Pharmaceuticals, Atlas Venture, Base Genomic, Biogen, BioNTech, Casma Therapeutics, Celsius Therapeutics, Eirion Therapeutics, FogPharma, FORMA Therapeutics, Gilead, Ginkgo BioWorks, Kernal Biologics, LogicBio Therapeutics, Mereo BioPharma, Olema Pharmaceuticals, Progenics Pharmaceuticals, Regeneron Pharmaceuticals, ReNetX Bio, Scipher Medicine Corporation, STIMIT Corporation, Syros Pharmaceuticals, Third Rock Ventures, WAVE Life Sciences, and Venrock.
Brenda is a member of Choate’s Executive Committee.
Education
- Harvard Law School
- JD, 1998, cum laude
- University of California at San Francisco
- PhD, 1993
- Biochemistry and Molecular Biology
- Harvard University
- MA, 1988, magna cum laude
- Chemistry
- Harvard University
- AB, 1988, magna cum laude
- Chemistry
Lawyer Rankings
United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
(Leading lawyers)Choate, Hall & Stewart‘s Boston-based team is led by Charles Lyon, Brian Reese and Kristen Buteau, who offer expertise in patent-related life sciences work; alongside Charles Lyon, Brenda Herschbach Jarrell chairs the firm’s life sciences group, advising a broad array of companies, from clinical candidates to well-established organizations and institutions on biotech, pharmaceutical, and specialty chemical matters in particular. Atop its solid prosecution work, the team has a strong reputation for its post-grant and re-examination practice, with partner Stephanie Schonewald having handled a significant number of such matters at the PTAB.
Lawyer Rankings
- Leading lawyers United States > Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Patents: prosecution (including re-examination and post-grant proceedings) United States > Intellectual property
Top Tier Firm Rankings
Firm Rankings
- Insurance > Advice to insurers
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- M&A/corporate and commercial > Venture capital and emerging companies
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Real estate > Real estate
- Tax > US taxes: non-contentious
- Finance > Restructuring (including bankruptcy): corporate
- Finance > Commercial lending